by By Kelli Kennedy
A lawsuit filed in South Florida federal court alleges one of the nation's largest suppliers of HIV and AIDS medical care bilked federal Medicare and Medicaid programs in a $20 million scam that spanned 12 states.
Three former managers of the AIDS Healthcare Foundation filed the suit last week, alleging the company paid employees and patients kickbacks for patient referrals.
The company denied paying kickbacks or violating the law in any way, saying it would continue to care for thousands of HIV and AIDS patients around the U.S. while fighting the claims.
Employees were paid $100 bonuses for referring patients with positive test results to its clinics and pharmacies. The lawsuit alleges kickbacks started in 2010 at the company's California headquarters and spread to programs in Georgia, Louisiana and Florida.
Explore further: US fines Japanese pharma co $39 mn for doctor kickbacks
© 2015 The Associated Press. All rights reserved.
Medical Xpress on facebook
Related Stories
US fines Japanese pharma co $39 mn for doctor kickbacks
Daiichi Sankyo, the large Japanese pharmaceutical company, is being fined $39 million over kickbacks it paid doctors in the United States to prescribe its drugs, the US Justice Department said Friday.
Consumer group sues Aetna, alleges discrimination
A consumer advocacy group has filed a class-action lawsuit against Aetna Inc. saying a new policy violates the privacy of people with HIV and AIDS by requiring them to get their medications from its mail-order pharmacy.
Lawsuit alleges Apple shortchanges store workers
A proposed class-action lawsuit alleges Apple has been mistreating thousands of employees who haven't been paid while forced to wait in line to show they aren't trying to steal an iPhone, iPad or other merchandise from the ...
Authorities in US sue Novartis in kickback scheme
Novartis Pharmaceuticals Corp. paid kickbacks to a specialty pharmacy in exchange for recommending refills of a blood transfusion drug it produces, according to an amended complaint filed Wednesday in a civil case brought ...
Feds fine St. Louis drug maker $3.5 million
(AP)—A St. Louis-based drug maker is paying $3.5 million to settle a federal lawsuit that it illegally paid doctors to prescribe out-of-date antidepressants and sleep aids to Medicare and Medicaid patients.
Recommended for you
Museums offer array of programs for the disabled
On a recent Sunday, a group of museum visitors sat in front of a large canvas by the French artist Jean Dubuffet as their guide described the work—an abstract painting created with crumpled aluminum foil tinted with oil ...
Article highlights legal issues linked to physician extenders
(HealthDay)—The use of physician extenders (PEs; mainly physician assistants and nurse practitioners) may bring added legal risks to a practice, according to an article published in Medical Economics.
Medical device maker settles lawsuit for $4.4 million
Medtronic has agreed to pay $4.4 million to settle a lawsuit filed by the federal government accusing the company of selling medical devices made in China and Malaysia to the U.S. military.
2015 match sees high proportion of unmatched seniors
(HealthDay)—About 6.1 percent of U.S. allopathic medical school seniors in the National Resident Matching Program (NRMP) were not placed into first-year residency positions, with a higher percentage of ...
Odds of reversing ICU patients' preferences to forgo life-sustaining care vary, study finds
Intensive care units across the United States vary widely in how they manage the care of patients who have set preexisting limits on life-sustaining therapies, such as authorizing do-not-resuscitate (DNR) orders and prohibiting ...
Horizon Pharma buying Hyperion for about $1.1 billion
Horizon Pharma is buying Hyperion Therapeutics for about $1.1 billion, gaining two treatments for genetic disorders.
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
0 comments:
Post a Comment